# Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/oncotype-dx-recurrence-score-as-a-predictor-of-response-to-neoadjuvant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alison M. Pease,Luis Riba,Ryan Gruner,Nadine Tung,Ted A. James |
| Citations | 99 |
| DOI | 10.1245/s10434-018-07107-8 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2903832937 |
| PMID | 30542840 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Luis Riba](https://scholariq.org/researchers/luis-riba/)
- [Ted A. James](https://scholariq.org/researchers/ted-a-james/)

## Paper journal

- [Annals of Surgical Oncology](https://scholariq.org/journals/annals-of-surgical-oncology/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Medical Imaging Techniques and Applications](https://scholariq.org/topics/medical-imaging-techniques-and-applications/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.